Relation Between Darunavir Levels and Virological Efficacy, Integrated Proviral ADN and Resistance Mutations in HIV-infected Patients on Treatment With Darunavir/Ritonavir Monotherapy
Phase of Trial: Phase IV
Latest Information Update: 19 Sep 2015
At a glance
- Drugs Darunavir (Primary) ; Ritonavir
- Indications HIV infections
- Focus Pharmacokinetics; Therapeutic Use
- 01 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Jan 2013 Planned End Date changed from 1 Sep 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 05 Jun 2012 New trial record